Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing
04:10pm, Monday, 12'th May 2025
SAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on April 25, 2025, the Company received a notice from The Nasdaq Stock Market LLC (“Nasd
China Liberal Education Holdings Limited Receives Staff Determination Notice from Nasdaq and Plans to Appeal
04:05pm, Monday, 12'th May 2025
BEIJING , May 12, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), a China-based company that provides technological consulting services
Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 12'th May 2025
SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2025, the Compensation Committee of the Board of Directors granted non-qualif
American Bitcoin Announces Go-Public Transaction through Strategic Merger with Nasdaq-Listed Entity
06:30am, Monday, 12'th May 2025
Positions American Bitcoin to become a publicly traded vehicle for low-cost Bitcoin accumulation at scale MIAMI , May 12, 2025 /PRNewswire/ -- American Bitcoin Corp. ("American Bitcoin" or the "Compan
Nasdaq Recovery: 3 Artificial Intelligence (AI) Stocks That Are Still Too Cheap to Ignore
02:19pm, Sunday, 11'th May 2025
In case you missed it, tech stocks are rallying again.
Shopify Inc to Join the Nasdaq-100 Index® Beginning May 19, 2025
08:00pm, Friday, 09'th May 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Shopify Inc. (Nasdaq: SHOP), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®) and the Nasdaq-100
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:00pm, Friday, 09'th May 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:30pm, Friday, 09'th May 2025
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic canc
FEMTO Receives Nasdaq Delisting Determination and Plans to Appeal
05:20pm, Friday, 09'th May 2025
May 9, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO), a pioneering Femtech company formerly known as BYND Cannasoft Enterprises Inc., announced today that it has recei
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 09'th May 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 09'th May 2025
BRISBANE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 5, 2025, the Compensation Committee granted inducement awards consisting of non-qu
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 09'th May 2025
SAN FRANCISCO, May 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercializati
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 30, 2025
04:05pm, Friday, 09'th May 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 30, 2025, short interest in 3,156 Nasdaq Global MarketSM securities totaled 13,300,707,903 shares compared with 13
MetaVia Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
08:01am, Friday, 09'th May 2025
CAMBRIDGE, Mass. , May 9, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA) ("MetaVia"), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a priva
KWESST Regains Compliance with Nasdaq Minimum Bid Price Requirement
07:27pm, Thursday, 08'th May 2025
Ottawa, Ontario--(Newsfile Corp. - May 8, 2025) - KWESST Micro Systems Inc. (TSXV: KWE) (TSXV: KWE.WT.U) (NASDAQ: KWE) (NASDAQ: KWESW ("KWESST" or the "Company") is pleased to announce that it has rec
